Gautam Kumar
Cardiovascular Disease · Atlanta, GANPI 1437375391
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $18,804 of the $28,732 with a category attached, or 65.4%. It is spread thinly across 8 manufacturers, the largest accounting for just 24.0%. Reporting peaked in 2019 at $17,004 and has fallen 73.5% since, to $4,503 in 2025. Among cardiovascular disease clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 23 payments — averaging $1249.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Osprey Medical Inc$7K
- Vascular Solutions, Inc.$6K
- Cordis US CORP.$6K
- Teleflex LLC$5K
- Merit Medical Systems Inc$4K
- Angiodynamics, Inc.$38
- plus $40 from 2 others
Across 147 payments — averaging $4786.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cardiovascular Systems Inc.$239K
- Abbott$222K
- Philips North America LLC$135K
- M.a. Med Alliance S.A.$49K
- Gentuity, LLC$25K
- Penumbra, Inc.$18K
- plus $16K from 2 others
What the payments were for
- Consulting fees$18,80465%
- Speaking & faculty fees$3,50012%
- Travel & lodging$5,41919%
- Food & beverage$1,0094%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Osprey Medical Inc | 5 | $6,893 |
| Vascular Solutions, Inc. | 3 | $6,473 |
| Cordis US CORP. | 3 | $5,819 |
| Teleflex LLC | 5 | $5,003 |
| Merit Medical Systems Inc | 4 | $4,465 |
| Angiodynamics, Inc. | 1 | $38 |
| Philips North America LLC | 1 | $22 |
| Boston Scientific | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DyeVert$6,893
- Interventional Products$6,735
- CATHETERS - ARROW$4,503
- GUIDEWIRES$123
- TURNPIKE$115
How this compares
$28,732 in reported general payments places this provider in the 90th percentile of 640 cardiovascular disease providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 12 | $146 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Atlanta
- Joseph MillerAtlanta$573K
- Utpal PandyaAtlanta$221K
- Randolph MartinAtlanta$177K
- Mani VannanAtlanta$157K
- Victor CorriganAtlanta$114K
- Elizabeth OfiliAtlanta$107K
- Isida BykuAtlanta$78K
- Cindy GrinesAtlanta$75K
- Anekwe OnwuanyiAtlanta$56K
- Melvin EcholsAtlanta$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.